do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology πππππ¬π π©π¨π¬π’ππ’π¨π§ π¨π πππ-π π’π§π‘π’ππ’ππ¨π«π¬
Description
Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet
Data Availability Statement No new data were created or analyzed in this study.

Those brand-name drugs can cost more than $1,000 per month if they arent covered by insurance
The second article considers problems, side-effects and reasons to avoid GLP-1 and GIP/GLP-1 RAs, while the third reviews their role in weight management
